94. Cell therapy in a war on cancer, Kleanthis Xanthopoulos, Co-Founder & CEO, Shoreline Biosciences
Kleanthis is a serial biotechnology entrepreneur with over two decades of experience in the biotechnology and pharmaceutical research industries as an executive, company founder, chief executive offic...
16 Maalis 202225min
93. Human-centric data and AI for improved drug development, David Berry, Founder & CEO, Valo Health
David Berry is the Founder and CEO of Valo and since 2005, has served as General Partner at Flagship Pioneering, having founded over 25 companies including Indigo Agriculture, Seres Therapeutics (NASD...
9 Maalis 202233min
92. Software driven biology for small molecule mRNA drugs, Yochi Slonim, Co-founder & CEO, Anima
A serial entrepreneur in software and biotech, Yochi Slonim has built multiple companies as a founder and CEO through all phases of growth all the way to IPOs and large M&A exits. As a Co-founder and ...
2 Maalis 202240min
91. tRNA therapies, Lovisa Afzelius, Founding CEO, Theonie Anastassiadis, Co-founder & CIO, Alltrna
Lovisa Afzelius is an origination partner at Flagship Pioneering and the former SVP of Strategy & Operations at Flagship-founded Cogen Immune Medicines, now known as Repertoire Immune Medicines. A com...
23 Helmi 202228min
90. From pharma to founding a biotech, James Mackay, Founder, President & CEO, Aristea Therapeutics
James Mackay, PhD, Founder, President and Chief Executive Officer, has over 25 years of development and commercialization expertise in the pharmaceutical industry, including 6 drug product approvals a...
16 Helmi 202224min
89. Regenerative medicine pioneer, Laura Niklason, Founder, President, & CEO, Humacyte, Inc.
A physician-scientist, her groundbreaking work in vascular and lung engineering has made Dr. Niklason a world leader in regenerative medicine. She is a member of the National Academies of Engineering ...
9 Helmi 202233min
88. Biologics in autoimmune and kidney disease, Marshall Fordyce, CEO and Founder, Vera Therapeutics
Dr. Fordyce brings more than 15 years’ experience leading teams in drug discovery, development, clinical translation, and commercialization of new treatments. Before founding Vera, Fordyce was the fo...
2 Helmi 202220min
87. Patient-centric Duchenne gene therapy, Joel Schneider, COO, Solid Biosciences
Dr. Schneider is the Chief Operating Officer for Solid Biosciences, responsible for overseeing corporate and technical operations, quality, patient advocacy, communications, corporate strategy, and hu...
26 Tammi 202234min
